Drug
Sevelamer clinical trials
Also written Renvela and Renagel.
- studies test it
- 51
- open now
- 1
- in phase 3
- 14
- first study started
- 2000
Keep track of what changes. Save the Sevelamer studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Name
Combined with it in one product
Studies by the year they started
50 studies that test it; most in 2009 (7)
| Year | Studies |
|---|---|
| 2000 | 1 |
| 2003 | 1 |
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 3 |
| 2007 | 2 |
| 2008 | 5 |
| 2009 | 7 |
| 2010 | 5 |
| 2011 | 4 |
| 2012 | 3 |
| 2013 | 3 |
| 2014 | 4 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 3 |
| 2018 | 3 |
| 2024 | 1 |
By phase
A phase 1/2 study counts in both.
- Early Phase 1
- 1
- Phase 1
- 4
- Phase 2
- 14
- Phase 3
- 14
- Phase 4
- 6
- No phase
- 12
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 18 · Other 33
Genzyme, a Sanofi Company (11) · Centre Hospitalier Universitaire, Amiens (2) · The University of Texas Health Science Center at San Antonio (2) · University Hospital, Gentofte, Copenhagen (2) · Gulhane School of Medicine (2) · University of California, Los Angeles (1) · Sanofi (1) · Steno Diabetes Center Copenhagen (1)
Often tested with
Tested in the same studies.
Lanthanum carbonate (3) · Lanthanum (3) · Calcitriol (2) · Calcium acetate (2) · Calcium Carbonate (2) · DS-2330B (1) · Cholecystokinin (1) · SBR 759 (1)
Studies
Open first, then newest update. How each study uses Sevelamer is read from its arms, and is right about nine times in ten.
Testing it · 51
- Calcium-Phosphorus Regulation Therapy on Heart Valve DiseaseRecruitingPhase 4China National Center for Cardiovascular DiseasesNCT06660524Written as Sevelamer
- FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney DiseaseCompletedPhase 3Centre Hospitalier Universitaire, AmiensNCT01220843Written as Sevelamer carbonate
- FGF-23 (Fibroblast Growth Factor 23) Regulation in Chronic Kidney DiseaseCompletedNot applicableUniversity of California, Los AngelesNCT00999037Written as Sevelamer Carbonate
- Evaluation of Renvela in Patients With Chronic Kidney Disease Not On Dialysis And Hyperphosphatemia In ChinaCompletedPhase 3SanofiNCT03001011Written as Sevelamer Carbonate (GZ419831)
- Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim 1)CompletedPhase 2The University of Texas Health Science Center at San AntonioNCT02124759Written as Sevelamer
- GLP-1-mediated Gluco-metabolic Effects of Bile Acid SequestrationCompletedNot applicableSteno Diabetes Center CopenhagenNCT03739268Written as Sevelamer
- Different Effects of Non-calcium Phosphate Binders on Serum CalciumCompletedPhase 4Medical University of LodzNCT03451019Written as Sevelamer Hydrochloride
- The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy VolunteersCompletedPhase 1ShireNCT00925704Written as Sevelamer carbonate + Calcitriol
- Mechanism of Microbiome-induced Insulin Resistance in Humans (Aim2)CompletedPhase 2The University of Texas Health Science Center at San AntonioNCT02127125Written as Sevelamer
- Sevelamer Hydrochloride in Peritoneal Dialysis PatientsCompletedNot applicableThe University of Hong KongNCT00745589Written as sevelamer hydrochloride
- DS2330b Alone and With Sevelamer in Patients on Chronic HemodialysisCompletedPhase 1Daiichi SankyoNCT03305471Written as Sevelamer
- Sevelamer for Reducing Endotoxemia and Immune ActivationCompletedPhase 2Advancing Clinical Therapeutics Globally for HIV/AIDS and Other InfectionsNCT01543958Written as Sevelamer carbonate
- The Effect of Sevelamer Carbonate on Serum Trimethylamine-n-Oxide (TMAO) Level in Patients With Chronic Kidney Disease (CKD) Stage 3b-4Status unknownPhase 3Fan Fan HouNCT03596749Written as Sevelamer Carbonate
- Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney DiseaseCompletedEarly Phase 1Milton S. Hershey Medical CenterNCT01308242Written as Sevelamer Carbonate
- Arterial Stiffness and Calcifications in Haemodialysis Patients on Sevelamer or Calcium AcetateWithdrawnNot applicableRomanian Society of NephrologyNCT00364000Written as Sevelamer
- The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET ScanTerminatedNot applicableBrigham and Women's HospitalNCT01238588Written as Sevelamer Carbonate (Renvela)
- Hyperphosphatemia in Children With Chronic Kidney DiseaseStatus unknownPhase 3Assiut UniversityNCT03202407Written as Calcium acetate and sevelamer hydrochloride
- Effect of Bile Acid Secretion and Sequestration on GLP-1 SecretionCompletedNot applicableUniversity Hospital, Gentofte, CopenhagenNCT02445508Written as Sevelamer
- An Open Label, Dose Titration Study of Sevelamer Carbonate Tablets & Powder in Hyperphosphatemic CKD PatientsCompletedPhase 3Genzyme, a Sanofi CompanyNCT02332811Written as sevelamer carbonate 800mg
- Sevelamer and Secondary Hyperparathyroidism in Chronic Kidney DiseaseCompletedPhase 3Kenneth R. Phelps, M.D.NCT01191762Written as sevelamer carbonate
See all 51 studies that test Sevelamer →
Given in every arm · 5 — Sevelamer is usual care beside what is tested
- Drug-drug Interaction Study of TPOXX When Co-administered With Phosphate BindersCompletedPhase 4SIGA TechnologiesNCT04485039Written as sevelamer carbonate oral tablet
- A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HPCompletedPhase 4ArdelyxNCT03988920Written as Sevelamer Carbonate
- Study to Evaluate the Efficacy of Tenapanor as Adjunctive Therapy to Phosphate Binder TherapyCompletedPhase 2/3ArdelyxNCT03824587Written as Phosphate Binder Agents
- Study in Healthy Adult Subjects to Assess the Effect of Phosphate Binders on the Pharmacokinetics of a Single Dose of VadadustatCompletedPhase 1Akebia TherapeuticsNCT04299633Written as Sevelamer carbonate
- A Phase1 Study to Explore the Safety of EOS789 in Patients With Chronic Kidney Disease and Hyperphosphatemia on HemodialysisCompletedPhase 1Chugai PharmaceuticalNCT02965053Written as Renvela
As the comparator · 24 — what is tested is compared with Sevelamer
- Evaluate the Efficacy and Safety of JMKX003002 in End-Stage Renal Disease Patients on Hemodialysis with HyperphosphatemiaRecruitingPhase 2JemincareNCT06664125Written as Sevelamer carbonate
- A Phase III, Multicentre, Double-Blind, Placebo-Controlled Withdrawal Study in Patients With HyperphosphatemiaCompletedPhase 3Tanabe Pharma CorporationNCT00416520Written as Another phosphate binder (Sevelamer)
- A Study of MCI-196 in Chronic Kidney Disease Stage V Subjects on Dialysis With HyperphosphatemiaCompletedPhase 3Tanabe Pharma CorporationNCT00542815Written as Another Phosphate binder (Sevelamer)
- AP301 Efficacy and Safety in Chinese Dialysis Patients With HyperphosphatemiaCompletedPhase 3Alebund PharmaceuticalsNCT07030595Written as Sevelamer carbonate (Renvela®)
- Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisCompletedPhase 3Sinomune Pharmaceutical Co., LtdNCT04456803Written as Sevelamer carbonate tablet
- A Study to Evaluate Safety and Efficacy of AP-306 in Hyperphosphatemia PatientsCompletedPhase 2Alebund PharmaceuticalsNCT05764590Written as Sevelamer Carbonate
- A Phase 3 Study of Tenapanor to Treat Hyperphosphatemia in ESRD Patients on DialysisCompletedPhase 3ArdelyxNCT03427125Written as Sevelamer Carbonate
- A Phase 2 Study to Evaluate the Safety and Efficacy of VS-505(AP301) to Treat Hyperphosphatemia in Hemodialysis PatientsCompletedPhase 2Shanghai Alebund Pharmaceuticals LimitedNCT04551300Written as Sevelamer Carbonate
- Comparing Absorption of Dietary Phosphorus When Administering FOSRENOL® or RENVELA® in Healthy Adult VolunteersCompletedPhase 1ShireNCT00875017Written as Sevelamer
- Head to Head Study Against Sevelamer HydrochlorideCompletedPhase 3ShireNCT00441545Written as Sevelamer hydrochloride
- PA21 Safety and Efficacy in Adult Chinese SubjectsCompletedPhase 3Vifor Fresenius Medical Care Renal PharmaNCT03644264Written as sevelamer carbonate
- Ferric Citrate for the Treatment of Hyperphosphatemia in Patients With Chronic Kidney Disease Undergoing HemodialysisCompletedPhase 3Panion & BF Biotech Inc.NCT03984760Written as Sevelamer Carbonate
- Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on HemodialysisCompletedPhase 2Novartis PharmaceuticalsNCT00704483Written as Sevelamer HCl
- A Phase III Study of PA21 in Hemodialysis Patients With HyperphosphatemiaCompletedPhase 3Kissei Pharmaceutical Co., Ltd.NCT01850602Written as Sevelamer hydrochloride
- Equivalence of Calcium Acetate Oral Solution and Sevelamer Carbonate Tablets in Hemodialysis PatientsCompletedPhase 4Fresenius Medical Care North AmericaNCT01427907Written as Sevelamer carbonate
- A Comparative Study of ASP1585 in Chronic Kidney Disease Patients With Hyperphosphatemia on HemodialysisCompletedPhase 3Astellas Pharma IncNCT01057407Written as Sevelamer hydrochloride
- Randomized Study Comparing Genz-644470, Placebo, and Sevelamer Carbonate in Chronic Kidney Disease Patients on HemodialysisCompletedPhase 2Genzyme, a Sanofi CompanyNCT00853242Written as Sevelamer carbonate
- A Phase 3 Study to Investigate the Safety and Efficacy of PA21, a Phosphate Binder, in Dialysis PatientsCompletedPhase 3Vifor PharmaNCT01324128Written as Sevelamer carbonate
- A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis PatientsCompletedPhase 3Vifor PharmaNCT01464190Written as Sevelamer carbonate
- A Phase 1 Multiple Dose Study to Compare the Effects of AMG 223 and Sevelamer HCL (Renagel®)CompletedPhase 1Amgen Research (Munich) GmbHNCT00756860Written as Renagel® (sevelamer hydrochloride)
Showing 20 of 24.
Codes
What other systems call Sevelamer · ClinicalTrials.gg INT006618
- MeSH (NLM) D000069603SevelamerConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) 941N5DUU5CSEVELAMEROne source FDA
- RxNorm 214824One source FDA
- NCI Thesaurus C84172SevelamerOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000069603 | Sevelamer | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | 941N5DUU5C | SEVELAMER | One source FDA |
| RxNorm | 214824 | — | One source FDA |
| NCI Thesaurus | C84172 | Sevelamer | One source FDA |
Also registered as sevelamer carbonate (UNII 9YCX42I8IU · RxNorm 660890) and sevelamer hydrochloride (UNII GLS2PGI8QG · RxNorm 237125).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.